alopecia totalis
MONDO:0019080
Alopecia totalis is a form of alopecia areata, an inflammatory disease of the hair follicle, characterized by a complete loss of hair of the entire scalp which becomes glabrous.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
MONDO disease family
Recruiting studies by city
Trial status
Trial phase
Study start year
Investigated drug interventions
Alopecia totalis
Alopecia totalis is the loss of all hair on the head and face. Its causes are unclear, but it is believed to be an autoimmune disorder. Research suggests there may be a genetic link: the presence of DRB1*0401 and DQB1*0301, both of which are human leukocyte antigens (HLA), have been found to be associated with long-standing alopecia totalis.
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.